Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Lamotrigine chewable dispersible tablet

Drug Profile

Lamotrigine chewable dispersible tablet

Alternative Names: Lamotrigine CD; Lamictal CDT; Lamotrigine CD tablet; Lamotrigine chewable tablet; Lamotrigine dispersible tablet

Latest Information Update: 16 Aug 2023

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator GlaxoSmithKline
  • Developer GSK
  • Class Antidepressants; Antiepileptic drugs; Chlorobenzenes; Mood stabilisers; Small molecules; Triazines
  • Mechanism of Action Sodium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Bipolar disorders; Epilepsy

Most Recent Events

  • 04 Nov 2017 No recent reports of development identified for phase-I development in Epilepsy in China (PO, Fast dissolve)
  • 01 Dec 2015 GlaxoSmithKline completes a phase III trial in Bipolar disorders in China (NCT01602510)
  • 01 Nov 2015 GlaxoSmithKline completes a phase I trial In volunteers in China (PO) (NCT02513654)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top